Russia staged a communist plandemic back in 1979 similar to "covid"
(Natural News) It was the year 1979 when a mysterious pneumonia disease started spreading throughout the Russian Urals city of Yekaterinburg, ushering in a localized medical police state much like the one that is now being birthed on a global scale via the Wuhan coronavirus (Covid-19). Many people are unaware of the story, but it... (Source: NaturalNews.com)
Source: NaturalNews.com - July 24, 2021 Category: Consumer Health News Source Type: news

Clozapine treatment and risk of COVID-19 infection: retrospective cohort study, BJPsych
Abstract Background Clozapine, an antipsychotic with unique efficacy in treatment-resistant psychosis, is associated with increased susceptibility to infection, including pneumonia. Aims To investigate associations between clozapine treatment and increased risk of COVID-19 infection in patients with schizophrenia-spectrum disorders who are receiving antipsychotic medications in a geographically defined population in London, UK. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 22, 2021 Category: Consumer Health News Source Type: news

Systematic Review of VAP Diagnostics in Intensive Care Systematic Review of VAP Diagnostics in Intensive Care
A new review highlights the need for standardized diagnostic criteria for ventilator-associated pneumonia in critically ill patients.BMC Pulmonary Medicine (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 22, 2021 Category: Radiology Tags: Pulmonary Medicine Journal Article Source Type: news

RedHill Biopharma announces last patient out for phase 2/3 COVID-19 study of oral Opaganib
(RedHill Biopharma) RedHill Biopharma Ltd. (Nasdaq: RDHL), a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

New Merck pneumonia vaccine OK'd in US weeks after Pfizer's
U.S. regulators have approved a new pneumonia vaccine from Merck, more than a month after OK'ing an improved version of rival Pfizer’s shot (Source: ABC News: Health)
Source: ABC News: Health - July 16, 2021 Category: Consumer Health News Tags: Health Source Type: news

CT shines when it comes to COVID-19 risk stratification
CT has a key role to play in the diagnosis of COVID-19 pneumonia, accordin...Read more on AuntMinnie.comRelated Reading: HIV-positive people have higher incidence of coronary plaque AI can automatically quantify atherosclerosis on CCTA JAMA Internal Medicine stirs debate on coronary CT Machine learning plus CT boosts prediction of major coronary events Chest CT clarifies negative COVID-19 lab results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 16, 2021 Category: Radiology Source Type: news

Coronavirus Disease (COVID-19): A primer for emergency physicians
Conclusion: This narrative review provides clinicians with an updated approach to the evaluation and management of patients presenting to the emergency department with suspected COVID-19. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 16, 2021 Category: Consumer Health News Source Type: news

Staphylococcus aureus Ventilator-Associated Pneumonia: A Study of Bacterio-Epidemiological Profile and Virulence Factors
Ventilator-associated pneumonia (VAP) represents a major cause of nosocomial infections in the intensive care units in which Staphylococcus aureus is frequently involved. Better knowledge of this pathogen is required in order to enhance the patient's treatment and care. In this article, we studied the bacteriological profile and virulence factors of S. aureus-related VAP on a 3-year period. We included a collection of S. aureus strains (n = 35) isolated from respiratory samples from patients diagnosed with VAP in the intensive care units. We studied the bacteriological aspects and we searched for the presence of virulence ...
Source: Current Awareness Service for Health (CASH) - July 16, 2021 Category: Consumer Health News Source Type: news

Keeping translational science on the fast track to curb COVID-19 pneumonia
At the beginning of the pandemic, experimental therapies were the only options available to help patients. Turning them into standard care required clinical and translational research. Experts in the Mayo Clinic Center for Clinical and Translational Science helped make that happen. ____________________________________ "I think we've accomplished in this year what normally would take seven years," says Saad Kenderian, M.B., Ch.B., a Mayo Clinic cancer researcher.  Claudia Lucchinetti, M.D., director of Mayo Clinic's Center for Clinical and Translational Science,… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 16, 2021 Category: Databases & Libraries Source Type: news

Antibiotic - Resistant Pneumonia Is Killing Children in Bangladesh — Could It Spread?
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 15, 2021 Category: Respiratory Medicine Tags: Family Medicine, Infections, Pediatrics, Pulmonology, Preventive Medicine, News, Source Type: news

Antibiotic-Resistant Pneumonia Is Killing Children in Bangladesh — Could It Spread?
THURSDAY, July 15, 2021 -- Antibiotic-resistant bacteria is causing deadly pneumonia infections among large numbers of children in the South Asian nation of Bangladesh, a rising threat that could one day reach American shores, experts warn. Doctors... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 15, 2021 Category: General Medicine Source Type: news

Pandemic of antibiotic resistance is killing children in Bangladesh
(Massachusetts General Hospital) Young children with pneumonia in Bangladesh frequently do not respond to common antibiotics, often resulting in death. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 15, 2021 Category: Infectious Diseases Source Type: news

Low - Dose Aspirin Cuts Heart Risks in Patients Battling Pneumonia
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 8, 2021 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Neurology, Pulmonology, News, Source Type: news

Low-Dose Aspirin Cuts Heart Risks in Patients Battling Pneumonia
THURSDAY, July 8, 2021 -- Aspirin has long been taken by heart patients to reduce the risk of stroke and heart attack, but a new study suggests that it can also guard against cardiovascular trouble in pneumonia patients. Such complications are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 8, 2021 Category: General Medicine Source Type: news

Low-Dose Aspirin Cuts Heart Risks in Patients Battling Pneumonia
Title: Low-Dose Aspirin Cuts Heart Risks in Patients Battling PneumoniaCategory: Health NewsCreated: 7/8/2021 12:00:00 AMLast Editorial Review: 7/8/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 8, 2021 Category: Cardiology Source Type: news

Study shows aspirin can reduce the risk of heart attacks and strokes in patients with pneumonia
Aspirin can reduce the risk of serious cardiovascular events such as ischemic stroke and heart attack in patients with pneumonia, according to new research. (Source: University of Bristol news)
Source: University of Bristol news - July 7, 2021 Category: Universities & Medical Training Tags: Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Tony Black obituary
My friend Tony Black, who has died at 89 of pneumonia and emphysema, was my predecessor as chief psychologist at Broadmoor, the high-security psychiatric hospital in Berkshire.The son of Walter, a civil servant, and Rose (nee Foster), a former nurse, Tony was born between the wars in Sanderstead, Surrey, into a secure, loving family. Early experiences of growing up with a mentally and physically disabled sister, and counselling members of his battalion while on national service with the Royal Artillery, set him on the pathway for life as a psychologist.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 5, 2021 Category: Science Authors: Derek Perkins Tags: Psychology Source Type: news

Asymptomatic adults may be reservoirs of Streptococcus pneumoniae
(Instituto de Tecnologia Qu í mica e Biol ó gica Ant ó nio Xavier da Universidade NOVA de Lisboa ITQB NOVA) In Europe, S. pneumoniae is the most common cause of community-acquired bacterial pneumonia in adults. Still, very little is known about its colonization within this age group. A team of researchers from ITQB NOVA has now taken a crucial step to clarify the dynamics of carriage of this bacterium in adults. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 5, 2021 Category: Infectious Diseases Source Type: news

Bradycardia: Pneumonia, PE, ACS, or Anxiety?
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - July 1, 2021 Category: Emergency Medicine Tags: Bradycardia Source Type: news

Streptococcus pneumoniae sticks to dying lung cells, worsening secondary infection following flu
(University of Alabama at Birmingham) Researchers have found a further reason for the severity of dual infection by influenza and Streptococcus pneumonia -- a new virulence mechanism for a surface protein on the pneumonia-causing bacteria S. pneumoniae. This insight comes 30 years after discovery of that surface protein, called pneumococcal surface protein A. This mechanism had been missed in the past because it facilitates bacterial adherence only to dying lung epithelial cells, not to living cells. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

How Do People Get Pneumonia
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 23, 2021 Category: General Medicine Source Type: news

Relationship Between VAP and Mortality in COVID-19 Patients Relationship Between VAP and Mortality in COVID-19 Patients
A new analysis explores the possible relationship between ventilator-associated pneumonia and mortality risk among critically ill COVID-19 patients.Critical Care (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 22, 2021 Category: Intensive Care Tags: Critical Care Journal Article Source Type: news

Nigeria: How to Prevent Childhood Deaths From Pneumonia in Nigeria - Medical Doctor
[Premium Times] Medical doctor urges Nigeria to address harmful norms, behaviours and practices that put children at greater risk of pneumonia. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 22, 2021 Category: African Health Source Type: news

In Texas-Mexico Border Towns, COVID-19 Has Had an Unconscionably High Death Toll
Alfredo “Freddy” Valles was an accomplished trumpeter and a beloved music teacher for nearly four decades at one of the poorest middle schools in El Paso, Texas. He was known for buying his students shoes and bow ties for their band concerts, his effortlessly positive demeanor and his suave personal style—“he looked like he stepped out of a different era, the 1950s,” says his niece, Ruby Montana. While Valles was singular in life, his death at age 60 in February 2021 was part of a devastating statistic: He was one of thousands of deaths in Texas border counties—where coronavirus mortalit...
Source: TIME: Health - June 22, 2021 Category: Consumer Health News Authors: René Kladzyk, Phil Galewitz and Elizabeth Lucas | El Paso Matters and KHN Tags: Uncategorized COVID-19 Source Type: news

Health care leaders call for national focus on preventing hospital-acquired pneumonia
(University of Massachusetts Amherst) A group of health care leaders, including a University of Massachusetts Amherst nurse innovator, has published a national call to action to prevent non-ventilator-associated, hospital-acquired pneumonia (NVHAP). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2021 Category: International Medicine & Public Health Source Type: news

RedHill announces presentation of positive oral opaganib phase 2 data in COVID-19
(RedHill Biopharma) RedHill Biopharma Ltd. (Nasdaq: RDHL), a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva ® , ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2021 Category: Infectious Diseases Source Type: news

Zambia: Kenneth Kaunda - the Flawed Giant Who Squared Up to Colonialism and Aids
[Daily Maverick] Kenneth Kaunda, Zambia's founding president and anti-colonial hero, who governed one of the world's biggest copper producers between 1964 and 1991, has died of pneumonia at a military hospital in the capital Lusaka. He was 97. Kaunda was the last survivor of his peers in the group of 20th-century African anti-colonial figures such as Nelson Mandela. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - June 18, 2021 Category: Infectious Diseases Source Type: news

Is methicillin-resistant Staphylococcus aureus a common pathogen in ventilation-associated pneumonia?: The experience of a tertiary teaching hospital in Jordan
Abstract: Ventilator-associated pneumonia is a life threatening device related infection in intensive care units. Methicillin-resistant Staphylococcus aureus is considered a common contagious pathogen causing pneumonia and sepsis. To assess the prevalence of S aureus in comparison to other pathogens, and their antibacterial sensitivity profile in ventilator-associated pneumonia. Data regarding ventilator-associated pneumonia of adults admitted to the intensive care unit, at the Jordan University of Science and Technology Hospital, between 2012 and 2018 were extracted from the computerized system. Microorganisms and their s...
Source: Current Awareness Service for Health (CASH) - June 17, 2021 Category: Consumer Health News Source Type: news

Evaluation of the timing of MRSA PCR nasal screening: How long can a negative assay be used to rule out MRSA-positive respiratory cultures? "
Conclusion We report high NPVs for up to 2 weeks between specimen collections, which allows clinicians to use a negative MRSA PCR nasal screen assay to rule out MRSA pneumonia, potentially leading to decreased exposure to MRSA-active antibiotics. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 17, 2021 Category: Consumer Health News Source Type: news

Pneumocystis pneumonia outbreak chronicled in Clinical Infectious Diseases
Yale physicians helped track down the first confirmed U.S. outbreak of a fungus-driven pneumonia often seen in highly immunocompromised patients. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 16, 2021 Category: Universities & Medical Training Source Type: news

FDA Approves 20-Valent Pneumococcal Vaccine (Prevnar) FDA Approves 20-Valent Pneumococcal Vaccine (Prevnar)
The vaccine is capable of protecting against 20 serotypes involved in most cases of invasive pneumonia and pneumococcal disease in the US. This may be a significant advance in reducing pneumonia.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2021 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

Burns and fatal acute lung injury ignited by a smartphone charger during non-invasive ventilation for CoViD-19 - Shah SL, Barie PS, Bronstein ME, Chang PH, Gibson CJ, Houng AP, Kelly AE, Lee C, Lodescar RJ, Mahadev S, Shou J, Smith KE, Villegas CV, Winchell RJ, Narayan M.
As the coronavirus disease 2019 (COVID-19) pandemic rages, understanding of disease pathophysiology evolves [1]. Because the primary transmission mode is respiratory droplets, pneumonia is the predominant serious manifestation, requiring oxygen therapy (if... (Source: SafetyLit)
Source: SafetyLit - June 14, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Forty years of HIV/AIDS: Will the epidemic end?
June marks the 40th anniversary of the first scientific report describing pneumocystis pneumonia, which later became known as acquired immune deficiency syndrome (AIDS). More than 32 million people have died worldwide from AIDS and 38 million people are living with HIV, the virus that causes AIDS, according to the Centers for Disease Control and Prevention. "The last 40 years of [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 14, 2021 Category: Databases & Libraries Source Type: news

New Phase 3 Study Results Show IMBRUVICA ® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukemia
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the pivotal Phase 3 GLOW study (NCT03462719) evaluating fixed-duration IMBRUVICA® plus venetoclax (I+V) compared to chlorambucil plus obinutuzumab (Clb+O) for first-line treatment of elderly or unfit patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study demonstrated superior progression-free survival (PFS) of a once-daily, all-oral, fixed-duration regimen of I+V versus Clb+O as first-line treatment of CLL; the study also showed improved duratio...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced overall survival (OS) results from the Phase 3 MAIA (NCT02252172) study showing the addition of DARZALEX® (daratumumab) to lenalidomide and dexamethasone (D-Rd) resulted in a statistically significant survival benefit over lenalidomide and dexamethasone (Rd) alone in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible for autologous stem cell transplant (ASCT) and were treated to progression.[1] These data were featured in the European Hematology Association (EHA) 2021 Virtual Press Briefin...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Study: Children with severe COVID-19 unlikely to receive same treatment as adults
More than one in 10 children hospitalized with COVID-19 experience complications such as irregular heartbeats, lung failure and symptoms of viral pneumonia, a study published Friday by JAMA Network Open found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 11, 2021 Category: Consumer Health News Source Type: news

Noninvasive Ventilation Tied to Higher Mortality Than CPAP in COVID-19 Pneumonia Noninvasive Ventilation Tied to Higher Mortality Than CPAP in COVID-19 Pneumonia
Compared with continuous positive airway pressure, use of noninvasive ventilation to treat acute respiratory failure secondary to COVID-19 pneumonia is tied to higher mortality, according to a new review.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 11, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

‘I Truly Did Find My Calling.’ Meet the Young People Shaping Health Care’s Post-Pandemic Future
The COVID-19 pandemic has been exhausting for the world’s health care workers, who have spent the last year-plus putting their lives on the line to keep the rest of us safe and healthy. Now, their tireless efforts are inspiring a new generation to join their ranks: applications to U.S. medical schools shot up nearly 20% in fall 2021, according to the Association of American Medical Colleges. Individual schools are reporting similar spikes—New York University’s Rory Meyers College of Nursing saw a 33% increase in applications this year over the previous year, for instance. To learn more about the people wh...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Source Type: news

Colds, Bronchitis Cases Resurged After Texas Eased COVID Rules
WEDNESDAY, June 9, 2021 -- After Texas relaxed COVID-19 restrictions, other respiratory illnesses -- such as colds, bronchitis and pneumonia -- made rapid rebounds. Pathologists from Houston Methodist Hospital found that the rhinovirus and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 9, 2021 Category: General Medicine Source Type: news

Lung, brain, and spinal cord abscesses after a near-drowning episode - Cervera-Hernandez ME, Szymczak W, Puius YA, Shuter J.
A 35-year-old man with a history of substance abuse was taken to the hospital after being rescued from a freshwater river where he had a near-drowning experience. He was treated in the ICU for aspiration pneumonia and had a favorable initial clinical cours... (Source: SafetyLit)
Source: SafetyLit - June 9, 2021 Category: International Medicine & Public Health Tags: Drowning, Suffocation Source Type: news

Africa: HIV 40 Years On - Four Action Points to End Aids As a Health Threat
[The Conversation Africa] On 5 June 1981 a short report of five cases of pneumocystis pneumonia in young homosexual men in Los Angeles marked the discovery of AIDS, the first pandemic of the 20th century caused by a completely new virus, HIV. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - June 9, 2021 Category: Infectious Diseases Source Type: news

FDA Approves Prevnar 20 (pneumococcal 20-valent conjugate vaccine) for Adults Ages 18 Years or Older
First approval of a conjugate vaccine that helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia,1,2,3,4,5,6,7 including seven responsible for 40% of pneumococcal disease cases and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 8, 2021 Category: Drugs & Pharmacology Source Type: news

RedHill Biopharma completes enrollment of oral opaganib phase 2/3 COVID-19 study
(RedHill Biopharma) RedHill Biopharma Ltd. (Nasdaq: RDHL), a specialty biopharmaceutical company, today announced that it has completed enrollment and randomized the last patient in the global Phase 2/3 study with opaganib (Yeliva ® , ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). A total of 475 patients were randomized, more than the planned 464. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2021 Category: International Medicine & Public Health Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Paratek Pharmaceuticals Announces FDA Approval of Nuzyra (omadacycline) Oral Only Dosing Regimen for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)
BOSTON, June 01, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 1, 2021 Category: Drugs & Pharmacology Source Type: news

Managing COVID-19 [NG191], NICE (updated 27th May 2021)
New recommendations have been added on colchicine to treat COVID-19 and existing recommendations on remdesivir for COVID-19 pneumonia have been updated. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 28, 2021 Category: Consumer Health News Source Type: news

Outcomes in Patients With SARS-CoV-2 Pneumonia Outcomes in Patients With SARS-CoV-2 Pneumonia
What have we learned about the impacts of SARS-CoV-2 pneumonia on lung function and quality of life?BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 27, 2021 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Kenya: Why Scientists Want Stopped Pneumonia Trial Revived
[Nation] An intense campaign by a Ugandan resident that halted a vital study on medical oxygen for children with pneumonia has done more harm than good, according to experts. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 26, 2021 Category: African Health Source Type: news

Updated Data Demonstrate Significant Improvement in Hematologic Complete Response with DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, N.J., May 26, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the Phase 3 ANDROMEDA study, which evaluated DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare blood cell disorder associated with the deterioration of vital organs, most notably the heart, kidneys and liver.[1] Longer-term results from a median follow-up of 20.3 months showed rates of hematologic complete response (hemCR) remained significantly higher in patients treated with DARZALEX FASPRO®...
Source: Johnson and Johnson - May 26, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

CRP Level May Help Guide Use of Tocilizumab in COVID Pneumonia CRP Level May Help Guide Use of Tocilizumab in COVID Pneumonia
It's worth considering tocilizumab in patients with moderate-to-severe COVID-19-associated pneumonia and high CRP levels, according to follow-up data from a randomized controlled trial.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 26, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news